Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users
| Autor: | Umar Shakur, Yasir N. Akhtar, Shade F. Adigun, Gary Smith, William A. Walker, Syed S. Husnain |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Percutaneous 030204 cardiovascular system & hematology Intracardiac injection Drug Users 03 medical and health sciences 0302 clinical medicine Medicine Humans Radiology Nuclear Medicine and imaging 030212 general & internal medicine Infectious disease (athletes) Substance Abuse Intravenous Retrospective Studies Endocarditis business.industry Septic shock General Medicine Cytoreduction Surgical Procedures Endocarditis Bacterial medicine.disease Debulking Surgery Treatment Outcome Respiratory failure Bacteremia Shock (circulatory) Tricuspid Valve medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 97(6) |
| ISSN: | 1522-726X |
| Popis: | OBJECTIVES A retrospective case series of a percutaneous approach to debulk tricuspid valve endocarditis (TVE) using an 8 French mechanical aspiration system in patients with a history of intravenous drug use (IVDU) was reported. IVDU associated TVE is increasing in the United States and is associated with high mortality despite early surgical debridement. Patients with advanced disease, shock, and respiratory failure may not be candidates for surgical debridement or replacement. These patients have recurrent events despite medical therapy METHODS: About 25 patients with IVDU associated TVE with persistent bacteremia confirmed by repeat blood cultures after 72 hr of sensitivity directed antibiotics and presence of pulmonary emboli confirmed by computed tomographic (CT) scan, who had undergone percutaneous aspiration were included. Patients were all deemed high risk for surgical debridement by a CT surgeon and evaluated by an infectious disease consultant. Procedures were performed under moderate sedation with intracardiac echo and a steerable guide with a CAT8 Penumbra aspiration catheter. RESULTS There were no intraprocedural deaths or complications. About 36% had septic shock on presentation. Survival of index hospitalization was 88%. Repeat blood cultures showed no growth on all surviving patients. Readmission rate was 4% (n = 1) at 1 month. About 40% (n = 2) patients with septic shock survived at 1 month compared with 100% survival (n = 20) in those without shock. Presence of septic shock was associated with reduced survival at 1 month (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text